An experimental lupus drug has just met another key goal in its journey to becoming the first approved treatment for the disease in over 50 years. The target of the new drug, known as Benlysta, is to suppress the response of the body’s immune system to lupus in an attempt to control the actions of a protein that becomes overactive in lupus patients. Share it
An experimental lupus drug has just met another key goal in its journey to becoming the first approved treatment for the disease in over 50 years. The 
embed
